CoChat
Sign Up
Cited by 239

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Understanding microRNAs in neurodegeneration

Eacker, Stephen M., Dawson, Ted M., Dawson, Valina L.·2009·Nature Reviews Neuroscience
DOI 10.1038/nrn2726PMC PMC4120241
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrn2726

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 38

  1. Kim, V. N., Han, J. & Siomi, M. C. Biogenesis of small RNAs in animals. Nature Rev. Mol. Cell Biol. 10, 126–139 (2009). · DOI · Paper page
  2. Vasudevan, S., Tong, Y. & Steitz, J. A. Cell-cycle control of microRNA-mediated translation regulation. Cell Cycle 7, 1545–1549 (2008). · DOI
  3. Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Rev. Genet. 9, 102–114 (2008). · DOI
  4. Visvanathan, J., Lee, S., Lee, B., Lee, J. W. & Lee, S. K. The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev. 21, 744–749 (2007). · DOI · Paper page
  5. De Pietri Tonelli, D. et al. miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex. Development 135, 3911–3921 (2008). · DOI · Paper page
  6. Cheng, L. C., Pastrana, E., Tavazoie, M. & Doetsch, F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nature Neurosci. 12, 399–408 (2009). · DOI · Paper page
  7. Fiore, R. et al. Mef2-mediated transcription of the miR379–410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. EMBO J. 28, 697–710 (2009). · DOI · Paper page
  8. Vo, N. et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc. Natl Acad. Sci. USA 102, 16426–16431 (2005). · DOI · Paper page
  9. Siegel, G. et al. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nature Cell Biol. 11, 705–716 (2009). · DOI · Paper page
  10. Chartier-Harlin, M. C. et al. α-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364, 1167–1169 (2004). · DOI · Paper page
  11. Rovelet-Lecrux, A. et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nature Genet. 38, 24–26 (2006). · DOI
  12. Sleegers, K. et al. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 129, 2977–2983 (2006). · DOI
  13. Theuns, J. et al. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am. J. Hum. Genet. 78, 936–946 (2006). · DOI
  14. Brouwers, N. et al. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. Brain 129, 2984–2991 (2006). · DOI
  15. Kim, J. et al. A microRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220–1224 (2007). · DOI · Paper page
  16. Schaefer, A. et al. Cerebellar neurodegeneration in the absence of microRNAs. J. Exp. Med. 204, 1553–1558 (2007). · DOI · Paper page
  17. Cuellar, T. L. et al. Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration. Proc. Natl Acad. Sci. USA 105, 5614–5619 (2008). · DOI
  18. Davis, T. H. et al. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci. 28, 4322–4330 (2008). · DOI · Paper page
  19. Choi, P. S. et al. Members of the miRNA-200 family regulate olfactory neurogenesis. Neuron 57, 41–55 (2008). · DOI
  20. Bateman, A. & Bennett, H. P. The granulin gene family: from cancer to dementia. Bioessays 30 Sep 2009 (doi:10.1002/bies.200900086). · DOI
  21. Cruts, M. et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442, 920–924 (2006). · DOI · Paper page
  22. Gass, J. et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum. Mol. Genet. 15, 2988–3001 (2006). · DOI
  23. Rademakers, R. et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum. Mol. Genet. 17, 3631–3642 (2008). · DOI
  24. Hebert, S. S. et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression. Proc. Natl Acad. Sci. USA 105, 6415–6420 (2008). · DOI · Paper page
  25. Bettens, K. et al. APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease. Hum. Mutat. 30, 1207–1213 (2009). · DOI
  26. Wang, G. et al. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of α-synuclein. Am. J. Hum. Genet. 82, 283–289 (2008). · DOI
  27. Rideout, H. J., Dietrich, P., Savalle, M., Dauer, W. T. & Stefanis, L. Regulation of α-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons. J. Neurochem. 84, 803–813 (2003). · DOI
  28. Skovronsky, D. M., Lee, V. M. & Trojanowski, J. Q. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu. Rev. Pathol. 1, 151–170 (2006). · DOI
  29. Wider, C. et al. FGF20 and Parkinson's disease: no evidence of association or pathogenicity via α-synuclein expression. Mov. Disord. 24, 455–459 (2009). · DOI
  30. Bilen, J., Liu, N., Burnett, B. G., Pittman, R. N. & Bonini, N. M. MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol. Cell 24, 157–163 (2006). · DOI
  31. Lee, Y. et al. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nature Neurosci. 11, 1137–1139 (2008). · DOI
  32. Zuccato, C. et al. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nature Genet. 35, 76–83 (2003). · DOI · Paper page
  33. Conaco, C., Otto, S., Han, J. J. & Mandel, G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc. Natl Acad. Sci. USA 103, 2422–2427 (2006). · DOI · Paper page
  34. Johnson, R. et al. A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol. Dis. 29, 438–445 (2008). · DOI · Paper page
  35. Midoux, P., Pichon, C., Yaouanc, J. J. & Jaffres, P. A. Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br. J. Pharmacol. 157, 166–178 (2009). · DOI
  36. Pena, J. T. et al. miRNA in situ hybridization in formaldehyde and EDC-fixed tissues. Nature Methods 6, 139–141 (2009). · DOI
  37. Chi, S. W., Zang, J. B., Mele, A. & Darnell, R. B. Argonaute HITS-CLIP decodes microRNA–mRNA interaction maps. Nature 460, 479–486 (2009). · DOI · Paper page
  38. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233 (2009). · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Eacker, S. M., Dawson, T. M., & Dawson, V. L.
Venue
Nature Reviews Neuroscience
Publisher
Springer Science and Business Media LLC
Published
2009-11-11
Volume
10
Issue
12
Pages
837-841
ISSN
  • 1471-003X
  • 1471-0048
DOI
10.1038/nrn2726
PMC
PMC4120241
Cited by
239
References
5
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review